Mitochondrial oxidative phosphorylation disorders in children: Phenotypic, genotypic and biochemical correlations in

Kothari Sonam1, Parayil Sankaran Bindu2, M M Srinivas Bharath3

  • 1Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India; Neuromuscular Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.

Mitochondrion
|November 10, 2016
PubMed

Insights

Mitochondrial oxidative phosphorylation (OXPHOS) disorders in children present with diverse neuromuscular symptoms. This Indian study correlated enzyme deficiencies with clinical, imaging, and genetic data, revealing significant heterogeneity.

Area of Science:

  • Biochemistry
  • Pediatric Neurology
  • Genetics

Background:

  • Mitochondrial oxidative phosphorylation (OXPHOS) disorders are a significant cause of pediatric neuromuscular diseases.
  • Accurate diagnosis requires integrating biochemical, clinical, imaging, and genetic data.

Purpose of the Study:

  • To investigate the spectrum of mitochondrial OXPHOS disorders in a large cohort of Indian children with neuromuscular conditions.
  • To correlate biochemical enzyme deficiencies with clinical phenotypes, imaging, histopathology, and genetic findings for diagnostic clarification.

Main Methods:

  • Assay of mitochondrial respiratory chain enzymes in muscle tissue from 85 children between June 2011 and December 2013.
  • Correlation of enzyme deficiencies with neurological findings, magnetic resonance imaging (MRI), histopathology, and genetic analysis (mtDNA, SURF1, POLG1&2).
  • Classification of patients into syndromic and non-syndromic presentations.

Main Results:

  • The most frequent deficiency was isolated complex I (60%), followed by multiple complexes (27%).
  • Common neurological presentations included ataxia (59%), hypotonia (59%), and involuntary movements (49%).
  • Genetic analysis identified variations in mitochondrial DNA (n=8), SURF1 (n=5), and POLG1 (n=3).

Conclusions:

  • Mitochondrial OXPHOS disorders in children exhibit a wide range of clinical and imaging phenotypes.
  • Significant genetic heterogeneity underlies these disorders, necessitating comprehensive diagnostic approaches.
  • This study provides crucial insights into pediatric mitochondrial disorders in India.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
980
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.9K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.6K